A new concept of action of hemostatic proteases on inflammation, neurotoxicity, and tissue regeneration

[1]  G. Reiser,et al.  New synthetic peptide protects neurons from death induced by toxic influence of activated mast cells via protease-activated receptor , 2016, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology.

[2]  J. Griffin,et al.  Activated protein C: biased for translation. , 2015, Blood.

[3]  A. Rezaie.  Protease-activated receptor signalling by coagulation proteases in endothelial cells , 2014, Thrombosis and Haemostasis.

[4]  E. Kiseleva,et al.  [Peptide-agonist of protease-activated receptor (PAR 1), similar to activated protein C, promotes proliferation in keratinocytes and wound healing of epithelial layer]. , 2014, Biomeditsinskaia khimiia.

[5]  J. Griffin,et al.  Cytoprotective-selective activated protein C therapy for ischaemic stroke , 2014, Thrombosis and Haemostasis.

[6]  C. Jackson,et al.  Activated protein C: A regulator of human skin epidermal keratinocyte function. , 2014, World journal of biological chemistry.

[7]  M. Hollenberg,et al.  Proteinase‐activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways , 2014, British journal of pharmacology.

[8]  Huiyun Zhang,et al.  Evaluation on Potential Contributions of Protease Activated Receptors Related Mediators in Allergic Inflammation , 2014, Mediators of inflammation.

[9]  R. Lefkowitz,et al.  Recent developments in biased agonism. , 2014, Current opinion in cell biology.

[10]  D. Polley,et al.  Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease , 2014, British journal of pharmacology.

[11]  V. Pinelis,et al.  Peptides analogous to tethered ligands liberated by activated protein C exert neuroprotective effects in glutamate-induced excitotoxicity , 2014, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology.

[12]  G. Reiser,et al.  Activated protein C and thrombin participate in the regulation of astrocyte functions , 2014, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology.

[13]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[14]  Kristian Thorlund,et al.  Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies: A Network Meta-Analysis , 2014, Circulation.

[15]  J. Griffin,et al.  Activated Protein C Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive Rats , 2013, Stroke.

[16]  M. Hollenberg,et al.  Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact , 2013, Cell Communication and Signaling.

[17]  C. Esmon,et al.  Protein C and acute inflammation: a clinical and biological perspective. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[18]  K. Engelhard,et al.  High dose infusion of activated protein C (rhAPC) fails to improve neuronal damage and cognitive deficit after global cerebral ischemia in rats , 2013, Neuroscience Letters.

[19]  E. Bouwens,et al.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway , 2013, Journal of thrombosis and haemostasis : JTH.

[20]  S. Goldman,et al.  An Activated Protein C Analog Stimulates Neuronal Production by Human Neural Progenitor Cells via a PAR1-PAR3-S1PR1-Akt Pathway , 2013, The Journal of Neuroscience.

[21]  J. Griffin,et al.  Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. , 2012, Blood.

[22]  I. Canto,et al.  Allosteric modulation of protease-activated receptor signaling. , 2012, Mini reviews in medicinal chemistry.

[23]  S. Traynelis,et al.  Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop. , 2012, Cellular signalling.

[24]  M. Hollenberg,et al.  Targeting proteinase-activated receptors: therapeutic potential and challenges , 2012, Nature Reviews Drug Discovery.

[25]  J. Trejo,et al.  Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds , 2011, Proceedings of the National Academy of Sciences.

[26]  T. van der Poll,et al.  Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia , 2011, Thrombosis and Haemostasis.

[27]  R. Lefkowitz,et al.  β-Arrestin-mediated receptor trafficking and signal transduction. , 2011, Trends in pharmacological sciences.

[28]  J. Griffin,et al.  Cytoprotective protein C pathways and implications for stroke and neurological disorders , 2011, Trends in Neurosciences.

[29]  R. Lefkowitz,et al.  Therapeutic potential of β-arrestin- and G protein-biased agonists. , 2011, Trends in molecular medicine.

[30]  Keshava Rajagopal,et al.  Teaching old receptors new tricks: biasing seven-transmembrane receptors , 2010, Nature Reviews Drug Discovery.

[31]  K. Fukudome,et al.  Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  S. Ishiwata,et al.  Activated protein C prevents glutamate- and thrombin-induced activation of nuclear factor-κB in cultured hippocampal neurons , 2010, Neuroscience.

[33]  F. Castellino,et al.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications. , 2010, Blood.

[34]  M. Karjalainen‐Lindsberg,et al.  Mast Cells as Early Responders in the Regulation of Acute Blood–Brain Barrier Changes after Cerebral Ischemia and Hemorrhage , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  S. Ishiwata,et al.  Endothelial protein C receptor is expressed in rat cortical and hippocampal neurons and is necessary for protective effect of activated protein C at glutamate excitotoxicity , 2009, Journal of neurochemistry.

[36]  R. Lefkowitz,et al.  Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. , 2009, Developmental cell.

[37]  H. ten Cate,et al.  Activated protein C: a promising drug with multiple effects? , 2009, Mini-Reviews in Medical Chemistry.

[38]  P. Kovanen.  Mast cells in atherogenesis: Actions and reactions , 2009, Current atherosclerosis reports.

[39]  J. Trejo,et al.  Caveolae are required for protease-selective signaling by protease-activated receptor–1 , 2009, Proceedings of the National Academy of Sciences.

[40]  J. Trejo,et al.  Proteases display biased agonism at protease-activated receptors: location matters! , 2009, Molecular interventions.

[41]  José A Fernández,et al.  Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1 , 2009, Thrombosis and Haemostasis.

[42]  José A Fernández,et al.  Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity , 2009, The European journal of neuroscience.

[43]  G. Zoppo.  Inflammation and the neurovascular unit in the setting of focal cerebral ischemia , 2009, Neuroscience.

[44]  M. Karjalainen‐Lindsberg,et al.  An emerging role of mast cells in cerebral ischemia and hemorrhage , 2009, Annals of medicine.

[45]  José A Fernández,et al.  Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1 , 2008, The Journal of Neuroscience.

[46]  L. Rumsh,et al.  [Various effects of serine proteinases, activated protein C and duodenase, on mast cells]. , 2008, Biomeditsinskaia khimiia.

[47]  M. Schwaninger,et al.  Neurological outcome and inflammation after cardiac arrest--effects of protein C in rats. , 2008, Resuscitation.

[48]  G. Reiser,et al.  Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: Localization, expression and participation in neurodegenerative diseases , 2008, Thrombosis and Haemostasis.

[49]  S. Ishiwata,et al.  Activated protein C via PAR1 receptor regulates survival of neurons under conditions of glutamate excitotoxicity , 2008, Biochemistry (Moscow).

[50]  J. Bae,et al.  Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand , 2008, Thrombosis and Haemostasis.

[51]  M. Hollenberg,et al.  Role of protease‐activated receptors in inflammatory responses, innate and adaptive immunity , 2008, Journal of leukocyte biology.

[52]  R. M. Adibhatla,et al.  Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. , 2008, CNS & neurological disorders drug targets.

[53]  L. Brass,et al.  Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin. , 2008, Blood.

[54]  M. Hollenberg,et al.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more , 2008, British journal of pharmacology.

[55]  A. Malik,et al.  Regulation of Endothelial Junctional Permeability , 2008, Annals of the New York Academy of Sciences.

[56]  K. Wright,et al.  Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation , 2008, British journal of pharmacology.

[57]  P. Kovanen,et al.  Activated Mast Cells Induce Endothelial Cell Apoptosis by a Combined Action of Chymase and Tumor Necrosis Factor-&agr; , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[58]  J. Bae,et al.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. , 2007, Blood.

[59]  A. Malik,et al.  Dual Regulation of Endothelial Junctional Permeability , 2007, Science's STKE.

[60]  J. Griffin,et al.  Activated Protein C Mutant with Minimal Anticoagulant Activity, Normal Cytoprotective Activity, and Preservation of Thrombin Activable Fibrinolysis Inhibitor-dependent Cytoprotective Functions* , 2007, Journal of Biological Chemistry.

[61]  S. Vannucci,et al.  Mast Cell Stabilization Limits Hypoxic-Ischemic Brain Damage in the Immature Rat , 2007, Developmental Neuroscience.

[62]  J. Trejo,et al.  Protease-activated receptor signaling: new roles and regulatory mechanisms , 2007, Current opinion in hematology.

[63]  J. Griffin,et al.  The cytoprotective protein C pathway. , 2007, Blood.

[64]  J. Bae,et al.  Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells , 2007, Proceedings of the National Academy of Sciences.

[65]  S. Ishiwata,et al.  Modulation of hippocampal neuron survival by thrombin and factor Xa , 2006, Biochemistry (Moscow).

[66]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[67]  C. Esmon.  The interactions between inflammation and coagulation , 2005, British journal of haematology.

[68]  S. Coughlin,et al.  Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.

[69]  B. Dahlbäck,et al.  Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure–Function Relationships and Molecular Recognition , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[70]  W. Ruf,et al.  Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling* , 2005, Journal of Biological Chemistry.

[71]  J. Garcia,et al.  Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.

[72]  B. Dahlback.  Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway : novel insights into structure-function relationships and molecular recognition , 2005 .

[73]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[74]  Thomas A Luger,et al.  Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. , 2005, Endocrine reviews.

[75]  N. Bunnett,et al.  Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.

[76]  W. Ruf,et al.  Activated protein C signals through the thrombin receptor PAR1 in endothelial cells , 2003, Journal of endotoxin research.

[77]  E. Kiseleva,et al.  Activation of mast cells induced by agonists of proteinase-activated receptors under normal conditions and during acute inflammation in rats. , 2003, European journal of pharmacology.

[78]  C. Esmon.  Protein C pathway in sepsis , 2002, Annals of medicine.

[79]  S. Coughlin.  Protease-activated Receptors in Vascular Biology , 2001, Thrombosis and Haemostasis.

[80]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[81]  L. Gelbert,et al.  Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis* , 2001, The Journal of Biological Chemistry.

[82]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[83]  Stanley Jacobson,et al.  Acute stress increases permeability of the blood–brain-barrier through activation of brain mast cells , 2001, Brain Research.

[84]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[85]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[86]  S. Strukova,et al.  On the two types of the thrombin high molecular substrates. , 1988, Thrombosis Research.

[87]  P. Reitsma,et al.  New fundamentals in hemostasis. , 2013, Physiological reviews.

[88]  A. Gils,et al.  Determination of coagulation and fibrinolysis markers upon anti-TAFI treatment in a mouse thromboembolism model , 2011 .

[89]  C. Jackson,et al.  Activated protein C--an anticoagulant that does more than stop clots. , 2008, The international journal of biochemistry & cell biology.

[90]  S. Strukova.  Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. , 2006, Frontiers in bioscience : a journal and virtual library.

[91]  Dougald M Monroe,et al.  What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[92]  L. O'Brien,et al.  Activated protein C and sepsis. , 2006, Frontiers in bioscience : a journal and virtual library.

[93]  A. Aggarwal,et al.  NF-kB transcription factor: a key player in the generation of immune response , 2006 .

[94]  Strukova Sm.  Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. , 2006 .

[95]  S. Strukova.  Thrombin as a Regulator of Inflammation and Reparative Processes in Tissues , 2004, Biochemistry (Moscow).

[96]  B. Engelmann,et al.  Intravascular tissue factor pathway – a model for rapid initiation of coagulation within the blood vessel , 2003, Thrombosis and Haemostasis.

[97]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[98]  Strukova Sm.  Thrombin as a Regulator of Inflammation and Reparative Processes in Tissues , 2001 .